T-Cure Biosciences
Dr. Kalbasi is a physician-scientist in the Department of Radiation Oncology at UCLA focused on new immune-based therapies for the treatment of sarcoma and melanoma. As a radiation oncologist, Dr. Kalbasi specializes in the treatment of sarcoma and melanoma and also leads clinical trials, including studies of adoptive T cell therapy. Dr. Kalbasi received his medical degree from the David Geffen School of Medicine at UCLA and completed his residency training at the University of Pennsylvania. His pre-and post-doctoral work was conducted as an HHMI-NIH research fellow at the National Cancer Institute, at the Abramson Cancer Center (University of Pennsylvania), and Jonsson Comprehensive Cancer Center (UCLA).
This person is not in the org chart
This person is not in any offices
T-Cure Biosciences
Founded by early pioneers of T cell receptor (TCR) therapy, T-Cure strives to find the cure for human cancer using its cutting-edge TCR-T technologies. Using its proprietary iSORT TCR discovery platform, T-Cure expects to rapidly grow its pipeline of therapy candidates. The Company believes its TCR holds great promise in treating patients unaddressed by current modalities.